Registered entities
AUGUSTINE THERAPEUTICS
Reg. No. 0722.705.230Belgium
Innovation
6 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 110 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Social engagement
Social engagement: 5.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Asabys Partners, V-Bio Ventures, PMV, VIB.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 5 | 42% |
Recent activity
2 Jun 2026
Event
2026 Scientific Sessions of the American Diabetes Association® (ADA)
4 May 2026
Event
Mini-Symposium: HDAC6 Inhibition as a Therapeutic Approach for Neuromuscular Diseases
30 Apr 2026
Event
BioEquity Europe 2026